相关实验视频
Updated: Jun 26, 2025

09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.4K
呼吸道疾病中的微RNA-26a:机制和治疗潜力
Xiaoshan Liu1, Qian Chen1, Shuxia Jiang1
1Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Noncoding RNA, Institute for Frontier Medical Technology, School of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, 201620, People's Republic of China.
Molecular biology reports
|May 8, 2024
概括
微RNAs (miRNAs),特别是miR-26a,在呼吸系统疾病中发挥着关键作用. 本综述探讨了miR-26a的功能和发展为肺部疾病的治疗点的挑战.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 微RNAs (miRNAs) 是基因表达的关键调节者.
- miR-26a与各种呼吸道疾病有关,包括肺炎,肺癌和COPD.
- 了解miR-26a的作用对于开发新疗法至关重要.
研究的目的:
- 审查miR-26a在呼吸系统疾病中的调节作用.
- 分析miR-26a作为治疗点的挑战和潜力.
- 讨论基于miR-26a的治疗方法的临床试验策略.
主要方法:
- 关于miR-26a和呼吸系统疾病的研究文献综述.
- 分析miR-26a在疾病发病的机制.
- 药物可用性挑战的评估:效率,交付,修改和非目标效应.
主要成果:
- miR-26a显著影响主要呼吸道疾病的发病和进展.
- 现有研究强调miR-26a作为一种潜在的治疗剂.
- 临床应用存在重大障碍,包括交付和特异性.
结论:
- miR-26a作为呼吸系统疾病的治疗点具有前景.
- 克服效率,交付和特异性的挑战对于临床翻译至关重要.
- 需要进一步的研究来实现miR-26a在肺部疾病中的治疗潜力.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Acute Respiratory Failure-V
135
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
135
Drugs Used in Lower Respiratory Disorders: Overview
424
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
424
Types of RNA
63.6K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.6K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K

